David DeNofrio

2.1k total citations
50 papers, 1.5k citations indexed

About

David DeNofrio is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, David DeNofrio has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 20 papers in Cardiology and Cardiovascular Medicine and 9 papers in Epidemiology. Recurrent topics in David DeNofrio's work include Transplantation: Methods and Outcomes (17 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Cardiac Structural Anomalies and Repair (7 papers). David DeNofrio is often cited by papers focused on Transplantation: Methods and Outcomes (17 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Cardiac Structural Anomalies and Repair (7 papers). David DeNofrio collaborates with scholars based in United States, United Kingdom and Mongolia. David DeNofrio's co-authors include Evan Loh, Leslie M. Shaw, Magdalena Korecka, Kenneth L. Brayman, Bruce Kaplan, Paul Mahoney, William F. McGhan, Eric J. Stanek, Yannick Le Meur and Teun van Gelder and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

David DeNofrio

48 papers receiving 1.5k citations

Peers

Countries citing papers authored by David DeNofrio

Since Specialization

Citations

This map shows the geographic impact of David DeNofrio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David DeNofrio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David DeNofrio more than expected).

Fields of papers citing papers by David DeNofrio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David DeNofrio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David DeNofrio. The network helps show where David DeNofrio may publish in the future.

Co-authorship network of co-authors of David DeNofrio

This figure shows the co-authorship network connecting the top 25 collaborators of David DeNofrio. A scholar is included among the top collaborators of David DeNofrio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David DeNofrio. David DeNofrio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tolerability and clinical efficacy of letermovir for primary cytomegalovirus prophylaxis after heart transplantation 2025 ·The Journal of Heart and Lung Transplantation ·Jennifer Chow, Amanda R. Vest, David DeNofrio, David R. Snydman	0
2	The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) III Randomized Controlled Trial 2023 ·American Heart Journal ·Jenica Upshaw, Susan W. Parker, Douglas Gregory, Benjamin Koethe, Amanda R. Vest, Ayan R. Patel, Michael S. Kiernan, David DeNofrio, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael Cantor, Marvin A. Konstam	3
3	Immunosuppression and Heart Transplantation 2021 ·Handbook of experimental pharmacology ·(unknown), Lynne M. Sylvia, David DeNofrio	7
4	Transcatheter Aortic Valve Replacement of a Bicuspid Aortic Valve in a Heart Transplant Recipient 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), David DeNofrio, Paul Gordon, Daniel Levine, Neel R. Sodha, (unknown), Eirini Apostolidou	3
5	BK Virus Nephropathy in Heart Transplant Recipients 2015 ·American Journal of Kidney Diseases ·(unknown), Monika Pilichowska, Helen W. Boucher, Matthew C. Kiernan, David DeNofrio, Lesley A. Inker	12
6	Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics 2011 ·Journal of Thoracic and Cardiovascular Surgery ·Michael S. Kiernan, Duc Thinh Pham, David DeNofrio, Navin K. Kapur	49
7	3D Echocardiography to Evaluate Right Atrial Pressure in Acutely Decompensated Heart Failure 2011 ·JACC. Cardiovascular imaging ·Ayan R. Patel, Alawi Alsheikh‐Ali, Jayanta Mukherjee, A. Evangelista, (unknown), (unknown), Jeffrey T. Kuvin, David DeNofrio, Natesa G. Pandian	42
8	The Economic Effect of a Tertiary Hospital-Based Heart Failure Program 2005 ·Journal of the American College of Cardiology ·Douglas Gregory, David DeNofrio, Marvin A. Konstam	5
9	Right ventricular dysfunction in chronic dilated cardiomyopathy and heart failure 2005 ·Coronary Artery Disease ·Andreas Brieke, David DeNofrio	37
10	Cyclosporine Monitoring With 2-Hour Postdose Levels in Heart Transplant Recipients 2005 ·Therapeutic Drug Monitoring ·Sandra Solari, Lee R. Goldberg, David DeNofrio, Yi‐Ju Li	10
11	Blood cyst of the mitral valve apparatus in a woman with a history of orthotopic liver transplantation 2004 ·Journal of the American Society of Echocardiography ·Jeffrey T. Kuvin, Pabitra Saha, Hassan Rastegar, Robert Salomon, Natesa G. Pandian, David DeNofrio	18
12	Pharmacokinetics and Concentration-Control Investigations of Mycophenolic Acid in Adults After Transplantation 2000 ·Therapeutic Drug Monitoring ·Leslie M. Shaw, Bruce Kaplan, David DeNofrio, Magdalena Korecka, Kenneth L. Brayman	112
13	Cardiomyopathy and embolization: risks and benefits of anticoagulation in sinus rhythm 2000 ·Current Cardiology Reports ·Robert W. Rho, David DeNofrio, Evan Loh	4
14	DETECTION OF ANTI-HLA ANTIBODY BY FLOW CYTOMETRY IN PATIENTS WITH A LEFT VENTRICULAR ASSIST DEVICE IS ASSOCIATED WITH EARLY REJECTION FOLLOWING HEART TRANSPLANTATION 2000 ·Transplantation ·David DeNofrio, Robert W. Rho, Francisco Morales, Malek Kamoun, Jane Kearns, (unknown), Bruce R. Rosengard, Michael A. Acker, Evan Loh	28
15	Preferences for treatment outcomes in patients with heart failure: Symptoms versus survival 2000 ·Journal of Cardiac Failure ·Eric J. Stanek, (unknown), William F. McGhan, David DeNofrio, Evan Loh	128
16	Extrinsic compression of the left main coronary artery by the pulmonary artery in patients with long-standing pulmonary hypertension 1999 ·The American Journal of Cardiology ·Steven M. Kawut, Frank E. Silvestry, Victor A. Ferrari, David DeNofrio, Leon Axel, Evan Loh, Harold I. Palevsky	32
17	Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure 1999 ·The American Journal of Cardiology ·Paul Mahoney, Stephen Kimmel, David DeNofrio, Peter Wahl, Evan Loh	104
18	Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: Report of a case with immunoelectron microscopy 1998 ·Human Pathology ·Susan C. Abraham, David DeNofrio, Evan Loh, (unknown), John E. Tomaszewski, Giuseppe G. Pietra, Carol Reynolds	30
19	Lipoprotein(a) levels and heart transplantation atherosclerosis 1998 ·American Heart Journal ·Gene Chang, David DeNofrio, Shashank Desai, Michael P. Kelley, Daniel J. Rader, Michael A. Acker, Evan Loh	12
20	CD3 δ and ϵ gene expression in CD3t-CD16+ natural killer cell clones derived from thymic precursors 1995 ·Human Immunology ·David DeNofrio, Gilbert Radcliff, Kent J. Weinhold, Stephen M. Denning	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact